Skip to Content

Calmare Therapeutics Inc CTTC

Rating as of

Morningstar’s Analysis

Valuation
Currency in USD
Is it the right time to buy or sell?
Find out with Morningstar Premium
Is it the right time to buy or sell?
Find out with Morningstar Premium

1-Star Price

PREMIUM

5-Star Price

PREMIUM

Economic Moat

PREMIUM

About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Company Profile

Business Description

Calmare Therapeutics Inc is US-based medical device company which is engaged in developing and commercializing products and technologies for chronic neuropathic pain. The key product of the company is Calmare Pain Therapy Device which is a non-invasive and non-addictive modality that can treat chronic, neuropathic pain. The company offers a non-pharmacological (no drugs), non-addictive (no narcotics) and non-invasive (over the skin) solution to chronic pain sufferers in an outpatient treatment setting.

Contact
1375 Kings Highway East, Suite 400
Fairfield, CT, 06824
T +1 203 368-6044
Sector Healthcare
Industry Medical Devices
Most Recent Earnings Dec 31, 2016
Fiscal Year End Dec 31, 2017
Stock Type Speculative Growth
Employees 7